Vaccination Cuts Risk for Myocardial Infarction, Stroke After COVID-19
Findings show lower hospitalization risk 31 to 120 days after COVID-19 infection
Thromboembolic Disorders
Sotagliflozin Under Review for Heart Failure Treatment
Sotagliflozin is an investigational dual sodium-glucose co-transporter types 1 and 2 (SGLT1, SGLT2) inhibitor.
Novel Factor XI Inhibitor Fast Tracked for Thrombosis Associated With Cancer
Abelacimab is a highly selective, fully human monoclonal antibody designed to inhibit both factor XI and its activated form, factor XIa.
Genetic Analyses Link Vitamin D Deficiency to Dementia Risk
In Mendelian randomization analyses, 25(OH)D associated with risk for dementia, but not stroke or neuroimaging outcomes
Novel 12-LOX Inhibitor Fast Tracked for Heparin-Induced Thrombocytopenia
VLX-1005 is a first-in-class, selective small molecule inhibitor of 12-lipoxygenase, a key target within the arachidonic acid pathway.
No Increase in Long-Term Mortality Seen With Peripheral Drug-Coated Devices
DCDs noninferior to non-DCDs for survival among older adults who underwent femoropopliteal artery revascularization
Dissolution Test Failure Prompts Recall of Anagrelide Capsules
Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test.
Guideline Updated for Management of Spontaneous ICH
Some in-hospital therapies and prophylactic treatments may confer no benefit or are potentially harmful and should be reconsidered
Espresso Consumption Linked to Increase in Serum Total Cholesterol
Consumption of three to five versus zero cups of espresso linked to increased S-TC in women and men, with greater increase for men
USPSTF Issues Recommendations on Aspirin Use to Prevent Cardiovascular Disease
These recommendations only apply to individuals who do not have a history of CVD and are not already taking daily aspirin.
